Picture of Takara Bio logo

4974 — Takara Bio News Story

0.000.00%
jp flag iconLast trade - 00:00
HealthcareBalancedMid CapNeutral

Table: Takara Bio -2020/21 group results

May 13 (Reuters)- 
          Takara Bio Inc. 
          CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)
                 Year ended      Year ended       Year to       NEXT    
              Mar 31, 2021    Mar 31, 2020   Mar 31, 2022     YEAR      
                 LATEST         YEAR-AGO        COMPANY       COMPANY   
                 RESULTS         RESULTS       FORECAST     H1 FORECAST 
  Sales           46.09           34.57          50.50         24.61    
               (+33.3 pct)     (-3.6 pct)     (+9.6 pct)    (+41.5 pct) 
  Operating       13.95            6.27          14.00          7.14    
              (+122.4 pct)     (+14.8 pct)    (+0.3 pct)    (+91.1 pct) 
  Recurring       14.16            6.35          14.20          7.22    
              (+123.1 pct)     (+12.1 pct)    (+0.3 pct)    (+89.0 pct) 
  Net
  Net              9.55            3.82           9.80          4.89    
              (+149.9 pct)     (+4.4 pct)     (+2.6 pct)   (+115.0 pct) 
  EPS           79.29 yen       31.72 yen      81.38 yen     40.61 yen  
  Ann Div       16.00 yen       8.00 yen       16.00 yen                
  -Q2 Div          NIL             NIL            NIL                   
  -Q4 Div       16.00 yen       8.00 yen       16.00 yen                
  
  NOTE - Takara Bio Inc..
  *Second Net profit row denotes profit attributable to owners ofthe parent 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4974.T

Recent news on Takara Bio

See all news